I think value investors should like at least one biotech stock: BioNTech (NASDAQ: BNTX). You can scoop up a share of BioNTech for less than $120 at the time of this writing. This German biotech ...

Novartis agreed late Monday to buy German drugmaker MorphoSys for roughly $2.9 billion, and the biotech stock catapulted to a nearly three-year high. Please watch the video at Investors.com ...

GILD entered into an exclusive option and license agreement with Tubulis, a Germany-based biotech company ... team of experts has just released the 5 stocks with the greatest probability of ...

Additionally, Novartis (NYSE:NVS) just bought German biotech MorphoSys for $2.9 billion. If you’re looking for the next potential buyout among biotech stocks, examine these three. The last time ...

few biotech-based drugs are produced in the country. “The federal government is pursuing the goal of bringing German biotech to the forefront in Europe, not only in terms of the number of ...